The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,N-Dipropyl-N'-[6-(trifluoromethoxy)benzothiazol-2-yl]-acetamidine ID: ALA1093765
PubChem CID: 44818642
Max Phase: Preclinical
Molecular Formula: C16H20F3N3OS
Molecular Weight: 359.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCN(CCC)/C(C)=N/c1nc2ccc(OC(F)(F)F)cc2s1
Standard InChI: InChI=1S/C16H20F3N3OS/c1-4-8-22(9-5-2)11(3)20-15-21-13-7-6-12(10-14(13)24-15)23-16(17,18)19/h6-7,10H,4-5,8-9H2,1-3H3/b20-11+
Standard InChI Key: JLBQGCAZDYEFIR-RGVLZGJSSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
4.6486 -5.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6474 -4.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3622 -4.0890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3604 -5.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0758 -5.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0761 -4.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8665 -4.2452 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.3549 -4.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8661 -5.5898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1799 -4.9180 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9326 -4.0899 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9320 -3.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9250 -2.4417 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.7570 -3.2611 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1070 -3.2670 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.5926 -4.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1803 -3.4891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4176 -4.2040 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8303 -3.4896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8299 -4.9186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6553 -3.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6549 -4.9189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0671 -5.6335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0681 -2.7756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
12 14 1 0
1 2 2 0
12 15 1 0
5 4 2 0
10 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
16 18 1 0
8 9 2 0
18 19 1 0
9 5 1 0
18 20 1 0
4 1 1 0
19 21 1 0
8 10 1 0
20 22 1 0
5 6 1 0
22 23 1 0
2 11 1 0
21 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.42Molecular Weight (Monoisotopic): 359.1279AlogP: 5.37#Rotatable Bonds: 6Polar Surface Area: 37.72Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.55CX LogP: 5.64CX LogD: 5.59Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.51Np Likeness Score: -1.77
References 1. Anzini M, Chelini A, Mancini A, Cappelli A, Frosini M, Ricci L, Valoti M, Magistretti J, Castelli L, Giordani A, Makovec F, Vomero S.. (2010) Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases., 53 (2): [PMID:19950903 ] [10.1021/jm901375r ]